Search

New MSK research helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.

… Thursday, March 28, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK)  helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of

Every day, your commitment to funding life-changing cancer research at Memorial Sloan Kettering is ensuring a brighter future for people with cancer around the world. Thank you for your continued support.

… Thursday, July 1, 2021 Woman with a pom pom at the Cycle for Survival event at MetLife Stadium Cycle for Survival participants gathered at MetLife Stadium in New Jersey on May 1 and 2, 2021, for a socially distanced outdoor ride. Woman with two pom poms on stage at the Cycle for Survival event at MetLife

MSK experts say the Shield blood test is not the best way to detect colorectal cancer and instead recommend colonoscopy or a stool test for those who can’t have a colonoscopy.

… Wednesday, August 13, 2025 Only about two-thirds of the people who should have a  colonoscopy  actually get one. In the quest to improve colorectal cancer screening rates, companies are developing tests that are less invasive. The first blood test to detect  colon cancer and  rectal cancer , called Shield

Los expertos de MSK afirman que el análisis de sangre Shield no es la mejor forma de detectar el cáncer colorrectal y, en su lugar, recomiendan la colonoscopia o un análisis de heces para aquellas personas que no pueden someterse a una colonoscopia.

… Wednesday, August 13, 2025 Solo alrededor de dos tercios de las personas que deberían realizarse una  colonoscopia  realmente lo hacen. En la búsqueda por mejorar las tasas de detección del cáncer colorrectal, las empresas están desarrollando pruebas menos invasivas. El primer análisis de sangre que

Jeffrey A. Drebin, MD, PhD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Drebin brings to MSK decades of experience as a world-class surgical oncologist specializing in pancreaticobiliary, upper gastrointestinal and liver surgery. He joins MSK from the Perelman School of Medicine of the University of Pennsylvania (UPenn) where he was most recently the John Rhea Barton Professor and Chairman of the Department of Surgery. Dr. Drebin formally assumes his new role as Peter Scardino, MD, steps down as Chairman after ten years of visionary leadership.

… Monday, February 27, 2017 VIDEO | 01:36 Meet MSK Surgeon Jeffrey Drebin MSK Surgeon Jeffrey Drebin, Chief Physician Executive, is an expert in pancreatic cancer and treating liver tumors. Learn more about surgery at MSK, which has among the country’s largest cancer surgery departments. Video Details

Three young investigators who have made major accomplishments in cancer research will be the recipients of the 2007 Paul Marks Prize for Cancer Research and will share a $150,000 award, announced Memorial Sloan Kettering Cancer Center (MSKCC).

… Wednesday, September 26, 2007 Biennial Award Honors Investigators Who Have Made Important Contributions to the Biological Understanding of Cancer Three young investigators who have made major accomplishments in cancer research will be the recipients of the 2007 Paul Marks Prize for Cancer Research and

Learn about the experiences and accomplishments of the 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program students during their ten-week course of study.

… Friday, September 12, 2014 Our 2014 Summer Undergraduate Research Program (SURP) came to an end on August 8 after a stimulating and successful summer. Twenty-four students were immersed in the scientific community at Memorial Sloan Kettering,  strengthening their basic research skills and giving them

Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.

… Thursday, March 25, 2010 Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.

Meet Monika Shah, MD, infectious disease specialist at Memorial Sloan Kettering.

… Friday, April 2, 2021 Monika Shah, MD , infectious disease specialist, Vice Chair of Education in the Department of Medicine, and Chair of Memorial Sloan Kettering’s Graduate Medical Education Committee, is everything you’d want in a good friend. She’s warm, compassionate, and easy to talk to — someone

Memorial Sloan Kettering Cancer Center has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department of Medicine.

… Thursday, September 5, 2013 Memorial Sloan Kettering Cancer Center (MSKCC) has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department